Le Lézard
Classified in: Health, Science and technology
Subject: AWD

Uganda Integrated Agriculture And Nutrition Project Awarded To Abt Associates


ROCKVILLE, Md., July 19, 2018 /PRNewswire/ -- Abt Associates has won a major project to improve agriculture and nutrition in Uganda. The Integrated Community Agriculture and Nutrition Activity is a five-year, $23.2M contract funded by the U.S. Agency for International Development.

(PRNewsfoto/Abt Associates)

The objective of the project is to increase the resilience of households and communities in Uganda by boosting agricultural productivity and access to markets, improving household nutrition and strengthening community governance.  

"Abt will work with Ugandan organizations to target school communities and surrounding local actors to accomplish these cross-sectoral goals," said Abt's Chief Business Officer Jay Knott. "The project also will improve the ability of village-level savings associations and community groups to support the development of livelihoods and community-based economic ventures."

Abt's partners include three local implementing organizations?Caritas Kotido, Caritas Kabale, and Children of the World Foundation?to work directly with communities they already serve, as well as a cadre of international thought leaders in nutrition, youth engagement, behavior change and IT mobile solutions development. They include The Manoff Group, Making Cents International, Mango Tree Educational Enterprises and Souktel.

About Abt Associates
Abt Associates is an engine for social impact, harnessing the power of data and grounded insight to bring people from vulnerability to security worldwide. We provide research, consulting and technical services globally, working in the areas of health, environmental and social policy and international development. http://www.abtassociates.com

SOURCE Abt Associates


These press releases may also interest you

at 08:16
On March 28, 2024, Orexo AB (publ), ("Orexo" or the "Company") (STO: ORX) successfully issued senior secured callable floating rate social bonds in an amount of SEK 500 million and with a tenor of four years (the "Bonds"). Pursuant to the terms and...

at 08:07
On the evening of May 5, Kexing Biopharm (stock code: 688136) announced it had obtained a "Certificate of GMP Compliance of a Manufacturer" granted by the Norwegian Medical Products Agency in accordance with the European Medicines Agency (EMA)...

at 08:05
Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company, today announced that management will present at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 15, 2024, at 3:35 pm ET. The presentation will...

at 08:05
Azitra, Inc. , a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced preclinical data from the Company's platform and pipeline. The data are being presented on Friday, May 10,...

at 08:05
Viridian Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that senior management will participate in the following upcoming...

at 08:05
$16.3 million in cash and cash equivalents at the end of Q1 2024 providing projected cash runway into Q1 2026 Third amendment made in Q1 to Cipla partnership results in the wind down of the PUR1900 Phase 2b study and allows for a significant...



News published on and distributed by: